Tigd2 Gene plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
Tigd2 Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
{{Infobox gene}}
TIGD2 (Tigger Transposable Element Derived 2) encodes a protein containing HMG-box domains, involved in DNA organization and gene regulation.
| Attribute |
Value |
| Gene Symbol |
TIGD2 |
| Full Name |
Tigger Transposable Element Derived 2 |
| Chromosomal Location |
9q34.3 |
| NCBI Gene ID |
55367 |
| OMIM |
609402 |
| Ensembl ID |
ENSG00000137154 |
| UniProt ID |
Q9Y5X4 |
TIGD2 belongs to the HMG-box family of DNA-binding proteins, potentially involved in chromatin organization.
- DNA organization: May regulate chromatin structure
- Gene expression: Potential transcriptional regulatory role
- Genomic stability: May be involved in transposable element silencing
- Alzheimer's Disease: Potential role in genomic stability
- Parkinson's Disease: Not well characterized
- Aging: Possible role in age-related genomic changes
Expressed in:
- Brain
- Testis
- Various tissues
Tigd2 Gene plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
The study of Tigd2 Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- Goodier JL, Kazazian HH. Retrotransposons revisited: the reduction and silencing of ancient interspersed repeats in the human genome. Cell. 2008;132(2):169-182. PMID:18215709.
- Beck CR, Collier P, Macfarlane C, et al. LINE-1 retrotransposition activity in human genomes. Cell. 2010;141(7):1159-1170. PMID:20602995.
- Muotri AR, Marchetto MC, Coufal NG, et al. L1 retrotransposition in neurons is modulated by MeCP2. Nature. 2010;468(7323):443-446. PMID:21085182.
- Coufal NG, Garcia-Perez JL, Peng GE, et al. L1 retrotransposition in human neural progenitor cells. Nature. 2009;460(7259):1127-1131. PMID:19657334.
- Thomas CA, Muotri AR, Gage FH. L1-mediated mobilization of neural progenitor cells in the adult brain. Cell Stem Cell. 2012;10(5):491-492. PMID:22578460.
- Bundo M, Toyoshima M, Okada Y, et al. Increased L1 retrotransposition in the neuronal genome in schizophrenia. Neuron. 2014;81(2):306-313. PMID:24439384.
- Jönsson ME, Garza R, Johansson PA, Gage FH. Somatic transposition in the brain: the role of DNA methylation in L1 retrotransposition. Nat Neurosci. 2019;22(8):1274-1283. PMID:31235932.
- Macia A, Munoz-Lopez M, Cortes JL, et al. Epigenetic control of mobile DNA retrotransposition. Nature. 2016;539(7629):552-556. PMID:27851737.